Peti Thuwajit Selected Research

Peti Thuwajit Research Topics

Disease

18	Neoplasms (Cancer) 07/2022 - 01/2003
16	Cholangiocarcinoma 10/2021 - 01/2003
9	Breast Neoplasms (Breast Cancer) 05/2022 - 09/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2005
3	Triple Negative Breast Neoplasms 07/2022 - 12/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 11/2020
2	Inflammation (Inflammations) 01/2018 - 01/2014
2	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 07/2004 - 07/2002
1	Colonic Neoplasms (Colon Cancer) 11/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Thrombocytopenia (Thrombopenia) 08/2014
1	Infections 08/2014
1	Colitis-Associated Neoplasms 01/2014
1	Carcinogenesis 01/2014
1	Carcinoma (Carcinomatosis) 09/2013
1	Liver Diseases (Liver Disease) 08/2012
1	Rickets (Rachitis) 07/2004
1	Nephrocalcinosis 07/2004
1	Failure to Thrive 07/2004
1	Acidosis 07/2004
1	autosomal recessive distal Renal tubular acidosis 07/2002

Drug/Important Bio-Agent (IBA)

6	PeriostinIBA 01/2021 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2007
4	CytokinesIBA 01/2021 - 01/2014
3	HMGB1 Protein (HMG1)IBA 05/2022 - 12/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2013
3	IntegrinsIBA 11/2020 - 09/2012
3	Estrogens (Estrogen)FDA Link 01/2018 - 08/2012
3	MucinsIBA 05/2008 - 08/2005
2	Interleukin-33IBA 10/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2014
2	Estrogen ReceptorsIBA 10/2017 - 08/2012
2	Trefoil Factor-1IBA 09/2013 - 04/2007
2	Trefoil FactorsIBA 08/2012 - 04/2007
2	Glycoproteins (Glycoprotein)IBA 05/2008 - 01/2003
2	dirhodium tetraacetate (DRTA)IBA 07/2004 - 07/2002
1	Ribosomal Proteins (Ribosomal Protein)IBA 07/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 07/2022
1	B7-H1 AntigenIBA 05/2022
1	Advanced Glycation End ProductsIBA 05/2022
1	NucleolinIBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Biological ProductsIBA 12/2021
1	ChemokinesIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 11/2020
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 11/2020
1	Pyruvate CarboxylaseIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 03/2020
1	Pharmaceutical PreparationsIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2017
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2017
1	Receptor for Advanced Glycation End ProductsIBA 10/2017
1	Phenobarbital (Luminal)FDA Link 10/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	LipidsIBA 01/2016
1	Conditioned Culture MediaIBA 12/2014
1	Neutralizing AntibodiesIBA 12/2014
1	Caspase 3 (Caspase-3)IBA 08/2014
1	Transaminases (Aminotransferases)IBA 08/2014
1	FR 180204IBA 08/2014
1	NitrogenIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2012
1	Mucin-6IBA 05/2008
1	theasinensin AIBA 01/2003
1	metaperiodate (periodate)IBA 01/2003
1	thiobarbituric acidIBA 01/2003
1	Blood Group Antigens (Blood Groups)IBA 01/2003
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2003
1	Protons (Proton)IBA 07/2002
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 07/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2014 - 09/2013
1	Immunotherapy 01/2022
1	Therapeutics 03/2020